Skip to content

Clinical trials

Kidney Diseases trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Country / region: Malaysia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20132
20152
20201
20212
20222
20233
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Bayer2
Anthera Pharmaceuticals1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1
HI-Bio, A Biogen Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Penang Hospital, Malaysia1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases18
Glomerulonephritis, IGA7
Renal Insufficiency, Chronic7
Glomerulonephritis5
Urologic Diseases4
Autoimmune Diseases2
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Immune System Diseases2
Kidney Failure, Chronic2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.